Indeed, functional studies demonstrated a role of MSI2 in maintaining stemness properties, metastatic capacity, in vitro and in vivo tumorigenic ability and promoting drug resistance either in HCC or pancreatic tumors [33,34,35,36]. This evidence concerns the gene MSI2 and hepatocellular carcinoma.